{"id":"https://openalex.org/W2980342135","doi":null,"title":"VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.","display_name":"VORTIOXETINE - THE NEW ANTIDEPRESSANT AGENT WITH PROCOGNITIVE PROPERTIES.","publication_year":2016,"publication_date":"2016-11-01","ids":{"openalex":"https://openalex.org/W2980342135","mag":"2980342135","pmid":"https://pubmed.ncbi.nlm.nih.gov/29634095"},"language":"en","primary_location":{"id":"pmid:29634095","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29634095","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Comparative Study"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112328292","display_name":"Ewelina Dziwota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ewelina Dziwota","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026848695","display_name":"Marcin Olajossy","orcid":"https://orcid.org/0000-0002-1001-3185","observed_orcids":["https://orcid.org/0000-0002-1001-3185"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marcin Olajossy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.33464567,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"73","issue":"6","first_page":"1433","last_page":"1437"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.5839999914169312},{"id":"https://openalex.org/keywords/procognitive-effects","display_name":"procognitive effects","score":0.7900000214576721},{"id":"https://openalex.org/keywords/cognitive-impairment","display_name":"cognitive impairment","score":0.6200000047683716},{"id":"https://openalex.org/keywords/serotonin-transporter","display_name":"serotonin transporter","score":0.8230000138282776},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.6029999852180481},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.6880000233650208},{"id":"https://openalex.org/keywords/hippocampal-plasticity","display_name":"hippocampal plasticity","score":0.7760000228881836},{"id":"https://openalex.org/keywords/learning-and-memory","display_name":"learning and memory","score":0.6949999928474426},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.6399999856948853},{"id":"https://openalex.org/keywords/antidepressant-side-effects","display_name":"antidepressant side effects","score":0.7149999737739563},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.7990000247955322}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9988240003585815},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.7409063577651978},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5351734161376953},{"id":"https://openalex.org/C169900460","wikidata":"https://www.wikidata.org/wiki/Q2200417","display_name":"Cognition","level":2,"score":0.5233924984931946},{"id":"https://openalex.org/C37000724","wikidata":"https://www.wikidata.org/wiki/Q50430226","display_name":"Serotonergic","level":4,"score":0.5187097191810608},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.5132872462272644},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.4646467864513397},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3684760332107544},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.364971399307251},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35121434926986694},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.18590980768203735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1493358612060547},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08485189080238342},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.055025309324264526},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000078784","descriptor_name":"Vortioxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003071","descriptor_name":"Cognition","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003863","descriptor_name":"Depression","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D018697","descriptor_name":"Nootropic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:29634095","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29634095","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta poloniae pharmaceutica","raw_type":"Comparative Study"},{"id":"mag:2980342135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29634095","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2548380697","https://openalex.org/W1718269887","https://openalex.org/W7141023480","https://openalex.org/W2529982181","https://openalex.org/W2790900264","https://openalex.org/W2140225047","https://openalex.org/W4200299146","https://openalex.org/W2511478827","https://openalex.org/W2580744534","https://openalex.org/W4293790530"],"abstract_inverted_index":{"Depression":[0],"symptoms":[1],"resulting":[2],"from":[3,301,346],"cognitive":[4,27,104,208,237],"function":[5,209],"impairment":[6],"are":[7,40],"emphasized":[8],"by":[9],"both":[10,160],"DSM-5":[11],"and":[12,20,57,68,88,99,146,163,168,187,273],"ICD-10":[13],"diagnostic":[14],"criteria":[15],"for":[16,79,166],"major":[17],"depressive":[18,21,36,196,215],"disorder":[19],"episodes.":[22],"Nonetheless,":[23],"the":[24,114,174,223,320,339],"role":[25],"of":[26,35,70,84,89,128,152,179,194,218,245,251,307,341],"dysfunctions":[28],"seem":[29],"to":[30,134,141,172,327],"remain":[31],"underestimated":[32],"in":[33,81,126,144,184,210,278,291,295,343],"case":[34],"disorders,":[37],"thus":[38],"they":[39],"rarely":[41],"perceived":[42],"as":[43,95,132,269,271,304],"therapeutic":[44],"target.":[45],"Vortioxetine":[46,73,335],"is":[47,65,74,201,255,268,315],"a":[48,66,202,260,305],"relatively":[49],"new,":[50],"multi-functional":[51],"agent.":[52],"With":[53,241],"its":[54,129,219,242],"unique":[55],"properties":[56],"strong":[58,94],"affinity":[59],"towards":[60],"serotonin":[61,252],"transporter":[62],"(5-HTT),":[63],"vortioxetine":[64,107,158,180,200,254,287],"modulator":[67],"stimulator":[69],"serotonergic":[71],"transmission.":[72],"an":[75],"antidepressant":[76,311],"drug":[77,205,314],"suitable":[78],"therapy":[80],"various":[82],"types":[83],"depression:":[85],"severe,":[86],"anxiety-associated,":[87],"elders.":[90],"It":[91,226,262],"acts":[92],"equally":[93],"SNRIs":[96],"or":[97],"agomelatine":[98,277],"has":[100,108,263],"favorable":[101],"effects":[102,324],"on":[103,181,222,236,248],"functioning.":[105],"Although":[106],"not":[109],"undergone":[110],"comprehensive":[111],"preclinical":[112,145],"testing,":[113],"available":[115],"data":[116],"indicate":[117],"that":[118,157,266],"this":[119],"particular":[120],"agent":[121],"may":[122,227,288,336],"be":[123,142,289],"more":[124,257,274],"advantageous":[125],"terms":[127],"procognitive":[130,283],"effects,":[131],"compared":[133],"other":[135,310],"drugs":[136],"-":[137],"which":[138],"often":[139],"seemed":[140],"analogous":[143],"clinical":[147],"testing.":[148],"In":[149,198,285],"vitro":[150],"examination":[151],"hippocampal":[153],"pyramidal":[154],"cells":[155],"revealed":[156],"improves":[159],"synaptic":[161],"transmission":[162],"neuroplasticity":[164],"responsible":[165],"memory":[167],"learning":[169],"patterns.":[170],"Contrary":[171],"fluoxetine,":[173],"long-term":[175],"treatment":[176,308],"with":[177,191,213,234,309,319,331],"use":[178],"mice":[182],"resulted":[183],"enhanced":[185],"visual":[186],"spatial":[188],"memory,":[189],"along":[190,330],"reduced":[192],"occurrence":[193],"typical":[195],"behavior.":[197],"addition,":[199,286],"very":[203],"first":[204],"efficiently":[206],"augmenting":[207],"adults":[211],"diagnosed":[212],"severe":[214],"episode,":[216],"irrespective":[217],"curative":[220],"potential":[221],"affective":[224],"sphere.":[225],"exert":[228],"even":[229],"stronger":[230],"direct":[231],"effect":[232],"(assessed":[233],"DSST)":[235],"functions":[238],"than":[239,258,276],"duloxetine.":[240],"supplementary":[243],"capacity":[244],"acting":[246],"directly":[247],"several":[249],"subtypes":[250],"receptors,":[253],"certainly":[256],"just":[259],"SSRI.":[261],"been":[264,299],"proved":[265],"it":[267],"effective":[270],"venlafaxine":[272],"efficient":[275],"MDD":[279],"treatment,":[280],"additionally":[281],"exerting":[282],"effects.":[284],"beneficial":[290],"overcoming":[292],"sexual":[293],"dysfunction":[294],"patients,":[296],"who":[297],"have":[298],"suffering":[300,345],"such":[302],"condition":[303],"result":[306],"agents.":[312],"The":[313],"generally":[316],"well":[317],"tolerated":[318],"most":[321],"prevalent":[322],"side":[323],"being":[325],"mild":[326],"moderate":[328],"nausea":[329],"(mostly":[332],"transient)":[333],"headaches.":[334],"significantly":[337],"improve":[338],"quality":[340],"life":[342],"patients":[344],"depression.":[347]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-10-25T00:00:00"}